News Good news for GSK’s next generation asthma drug Results mean patients could switch to once-daily inhaler use
News Propeller Health to bring smart inhaler tech to Novartis' Br... Partnership will focus on COPD in Europe.
News Stop obsessing about generic Advair, says GSK's Witty Growth elsewhere will soak up impact of US competitor, says Sir Andrew Witty.
News Novartis’ COPD combo show benefits in switching from establi... A new study suggests COPD patients experience improved lung function and breathlessness after direct switch from long-acting bronchodilators or steroid containing combination therapies to N
News Early filing gives GSK a boost in COPD Compelling data from FULFIL study puts GSK in pole position
Views & Analysis Digital Health Round-up – new President, new ideals? A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Novo Nordisk fight with KBP Bio will go to arbitration Singapore court keeps an asset freeze on KBP Bio, saying the merits of its dispute with Novo Nordisk over a licensing deal must go to arbitration.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
